Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Voresklinik Din praksispartner A.M.B.A Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   10.6% 4.2% 1.8% 5.3% 5.1% 16.0% 20.3% 16.0%   Credit score (0-100)   24 50 71 41 42 11 5 12   Credit rating   BB BBB A BBB BBB BB B BB   Credit limit (kDKK)   0.0 0.0 0.7 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   889 976 1,530 1,995 1,080 1,374 0.0 0.0   EBITDA   78.2 159 410 -39.3 -67.7 -208 0.0 0.0   EBIT   62.2 143 393 -61.3 -87.4 -392 0.0 0.0   Pre-tax profit (PTP)   59.4 69.2 362.5 -313.7 -91.7 -431.5 0.0 0.0   Net earnings   59.4 69.2 362.5 -313.7 -94.3 -431.7 0.0 0.0   Pre-tax profit without non-rec. items   59.4 69.2 363 -314 -91.7 -431 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 47.1 56.6 50.2 43.9 0.0 0.0   Shareholders equity total   111 314 785 537 473 57.2 -1,463 -1,463   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 1,463 1,463   Balance sheet total (assets)   317 615 1,404 1,203 845 780 0.0 0.0   Net Debt   -13.1 -239 -788 -833 -2.9 -473 1,463 1,463     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   889 976 1,530 1,995 1,080 1,374 0.0 0.0   Gross profit growth   20.4% 9.8% 56.8% 30.4% -45.9% 27.2% -100.0% 0.0%   Employees   1 2 2 2 2 4 0 0   Employee growth %   0.0% 100.0% 0.0% 0.0% 0.0% 100.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   317 615 1,404 1,203 845 780 0 0   Balance sheet change%   23.5% 94.1% 128.2% -14.3% -29.8% -7.7% -100.0% 0.0%   Added value   78.2 159.2 410.0 -39.3 -65.4 -208.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -32 -32 14 -28 -39 -190 -44 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.0% 14.7% 25.7% -3.1% -8.1% -28.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   20.5% 31.0% 39.0% 9.6% -8.5% -52.9% 0.0% 0.0%   ROI %   61.3% 67.9% 71.6% -37.1% -17.3% -162.1% 0.0% 0.0%   ROE %   32.3% 32.5% 66.0% -47.5% -18.7% -162.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   35.1% 51.1% 55.9% 44.6% 56.0% 7.3% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -16.8% -149.9% -192.2% 2,122.0% 4.3% 226.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.2 1.8 2.1 1.6 2.0 1.0 0.0 0.0   Current Ratio   1.2 1.8 2.1 1.6 2.0 1.0 0.0 0.0   Cash and cash equivalent   13.1 238.8 788.0 833.2 2.9 472.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   49.9 244.1 658.5 417.3 382.7 13.4 -731.4 -731.4   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   78 80 205 -20 -33 -52 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   78 80 205 -20 -34 -52 0 0   EBIT / employee   62 72 196 -31 -44 -98 0 0   Net earnings / employee   59 35 181 -157 -47 -108 0 0